Lyft, Uber, Occidental Petroleum and more

Check out the companies making headlines after the bell: 

Lyft, Uber — Shares of the ride-hailing duo dipped after a San Francisco Superior Court judge ruled that they convert California drivers from independent contractors to employees with benefits. Lyft lost 1.7{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} in extended trading, while Uber fell 1.5{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f}. 

Occidental Petroleum — Shares of Occidental Petroleum dropped 4{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} after the oil and gas company posted a wider-than-expected loss and booked a total impairment of $6.6 billion for the second quarter. Occidental reported a loss of $1.76 per share, worse than the $1.68 per share loss analysts were expecting, according to FactSet. 

Bed, Bath & Beyond — Shares of Bed Bath & Beyond slid more than 4{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} after the retailer said it has lifted the suspension of planned debt reductions, which had been implemented to soften the blow from the pandemic.

Simon Property Group — Shares of Simon Property Group fell 0.3{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} after the biggest U.S. mall owner posted disappointing revenue. Simon Property said its revenue for the second quarter fell about 24{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} to $1.06 billion, compared with estimates of $1.14 billion, according to Refinitiv. The stock gained more than 5{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} on Monday after the Wall Street Journal reported it was in talks with Amazon to turn shuttered Sears and J.C. Penney stores into warehouses.

Kodak — Shares of Kodak extended its slide in after-hours trading, falling more than 2{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} after losing 27{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} in regular trading on Monday. The declines came after the imaging pioneer’s deal with the government to produce drugs ran into a snag. The U.S. Development Finance Corporation tweeted Friday that it will “not proceed any further” until “allegations of wrongdoing [that] raise serious concerns … are cleared.”

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.